Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: Clin Cancer Res. 2015 Jan 21;21(6):1340–1347. doi: 10.1158/1078-0432.CCR-14-1178

Figure 6.

Figure 6

Posterior 3D volume rendering of fused PET/CT scans of mice bearing breast tumors in the upper right flank and treated with fulvestrant. Upper panel: 18F-FES PET representative images. 18F-FES uptake decreases in xenografts with increased dose of fulvestrant. The gallbladder and bowel show high uptake consistent with hepatobiliary excretion of 18F-FES. Lower panel: 18F-FDG PET representative images. There is no difference among groups in 18F-FDG uptake. Green arrows indicate tumor.